DER45-EV Gel from Sol-Gel files for IND

Written by on November 12, 2009 in Acne Treatments, New Rosacea Treatments with 0 Comments


News today that Sol-Gel Technologies has filed for Investigational New Drug for a product they are calling DED45-EV. This topical gel is targeted as a treatment for rosacea.

There doesn’t seem to be other copies of this release, or related information so this could just be a pure PR exercise.

The exact details of the active ingredients in this product are not being made public. So far, only PR speak along the lines of ““As Sol-Gel’s microcapsulation forms a protective barrier between the drug and the skin, we expect it to reduce irritation when applied to the relatively sensitive skin of rosacea patients,“said Dr. Stanley Shapiro, Sol-Gel’s Head of Skin Care Science & Technology.” is being published.

My guess back in July in Sol-Gel Trialling Benzoyl Peroxide (DER 45 EV) for Rosacea ? was that this topical gel was in fact benzoyl peroxide. Certainly the publicity so far from Sol-Gel has been related to acne and acne treatments.

Sol-Gel Anti-Acne Clinical Study Shows Significantly Improved Efficacy and Safety

“In the Sol-Gel kits, the proprietary silica microcapsules encase and continuously release the benzoyl peroxide, enabling a significant increase in efficacy and tolerance in comparison to products containing free benzoyl peroxide

As I said in July, many rosacea sufferers will know from their own experiences, many acne treatments are just too harsh for their sensitive rosacea skin.

If anyone sees some more information that confirms the makeup of DER45-EV please do let us know.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Discover more from Rosacea Support Group

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.